慢性鼻窦炎认知功能障碍:范围综述
CRS患者在主客观认知测评中表现差于对照,认知缺陷与疾病特异性生活质量严重度相关,且医疗或内镜鼻窦手术后认知测量改善。痴呆关联证据不一:UK Biobank分析报告阿尔茨海默病风险升高(HR 1.33),而两项韩国队列和2025年荟萃分析未发现关联。
要点
- 成人CRS患者主客观认知测评均差于对照,缺陷与SNOT-22等生活质量严重度相关。
- 药物或内镜鼻窦手术后认知测量改善,提示认知障碍可能可逆。
- CRS与痴呆关联证据矛盾,UK Biobank报告HR 1.33,韩国队列及2025荟萃分析无关联。
核心结论
- 成人CRS存在可测量的认知功能障碍,可能随治疗改善,并有神经炎症病理生理学依据。
- CRS是否导致新发痴呆证据存在争议,结局异质性限制综合,建议开发CRS特异性认知测量集。
研究设计与样本
- 范围综述,检索EMBASE、PubMed/MEDLINE、Web of Science、Cochrane Library、CINAHL和Global Index Medicus至2026年5月。
- 纳入标准为成人CRS正式临床诊断(AAO-HNS、EPOS或ICD编码)且报告至少一项验证性认知测量或认知障碍的原始研究,两名评价者独立筛选。
主要发现
- CRS成人在主观量表(CFQ、Neuro-QoL)和客观测评(MoCA、ANAM、眼动评估、P300)中表现差于对照。
- 认知缺陷与疾病特异性生活质量严重度(SNOT-22、RSDI)相关。
- 认知测量在药物治疗或内镜鼻窦手术后改善。
- 两项静息态fMRI分析发现眶额-楔前叶连接改变与鼻腔鼻窦炎症程度相关。
- UK Biobank分析(364,945名参与者中7,176例CRS)报告阿尔茨海默病风险升高(HR 1.33),两项韩国队列和2025年荟萃分析未发现关联。
关键数值与推荐
- 纳入研究需成人CRS正式临床诊断(AAO-HNS、EPOS或ICD编码)并报告至少一项验证性认知测量或认知障碍。
- 排除动物研究、综述、会议摘要和非CRS人群。
- UK Biobank分析报告CRS与阿尔茨海默病风险HR 1.33。
临床怎么用
- 对成人CRS患者可关注认知功能,使用MoCA等验证性工具评估。
- 认知缺陷与疾病特异性生活质量严重度相关,治疗CRS可能改善认知测量。
- CRS与痴呆的因果关系不确定,不宜据此常规进行痴呆筛查或预后告知。
局限性
- 结局异质性妨碍荟萃分析。
- 痴呆关联证据矛盾,来源队列差异可能影响结果。
- 范围综述设计不提供效应量合并估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cognitive dysfunction is increasingly recognized as an extra-nasal manifestation of chronic rhinosinusitis (CRS). This scoping review characterizes the primary evidence on cognition in adult CRS, covering measures, treatment response, and incident dementia. METHODS: We searched EMBASE, PubMed/MEDLINE, Web of Science, the Cochrane Library, CINAHL, and Global Index Medicus through May 2026 using a MeSH and free-text strategy. Inclusion criteria include primary studies of adult CRS with a formal clinical diagnosis (AAO-HNS, EPOS or ICD-coded) reporting at least one validated cognitive measure or recognized cognitive impairment. Two reviewers screened independently. Animal studies, reviews, conference abstracts, and non-CRS populations were excluded. PRISMA-ScR reporting was performed; heterogeneity precluded meta-analysis. RESULTS: Twenty-four primary studies met inclusion criteria. Adults with CRS perform worse than controls on subjective (Cognitive Failures Questionnaire [CFQ], Neuro-QoL) and objective (Montreal Cognitive Assessment [MoCA], Automated Neuropsychological Assessment Metrics [ANAM], eye movement assessment, P300) cognitive instruments. Deficits correlate with disease-specific QoL severity (SNOT-22, Rhinosinusitis Disability Index [RSDI]). Cognitive measures improve after medical therapy or endoscopic sinus surgery. Two resting-state fMRI analyses identified altered orbitofrontal-precuneus connectivity scaling with sinonasal inflammation. Dementia results are mixed: a UK Biobank analysis (7176 CRS cases among 364,945 participants) reported increased Alzheimer disease risk (HR 1.33), while two Korean cohorts and a 2025 meta-analysis found no association. CONCLUSION: Adults with CRS show measurable cognitive dysfunction that may improve with treatment, with a plausible neuroinflammatory pathophysiology. Whether this translates to incident dementia is contested. Outcome heterogeneity limits synthesis; therefore, development of a CRS-specific cognitive measurement set is recommended.
引用
- O'Neil LM, Qureshi HA, Lindemann L, et al. Cognitive Dysfunction in Chronic Rhinosinusitis: A Scoping Review. Int Forum Allergy Rhinol. 2026. PMID: 42667649. doi:10.1002/alr.70262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。